Revium Rx (RVRC) Share-based Compensation (2024 - 2026)

Revium Rx has disclosed Share-based Compensation across 3 years of filings, most recently posting $3.5 million for Q2 2026.

• In Q2 2026, Share-based Compensation rose 2192.21% year-over-year to $3.5 million; the TTM figure through Jun 2026 stood at $3.5 million (changed N/A YoY), while the FY2025 annual figure was $4.3 million, down 13.91% from the prior year.
• Share-based Compensation came in at $3.5 million for Q2 2026 at Revium Rx, down from $4.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $5.0 million in Q4 2024 to a low of $154000.0 in Q2 2025.
• Average Share-based Compensation over 3 years is $3.2 million, with a median of $3.9 million recorded in 2025.
• Year-over-year, Share-based Compensation slipped 13.91% in 2025 and soared 2192.21% in 2026.
• Over 3 years, Share-based Compensation stood at $5.0 million in 2024, then dropped by 13.91% to $4.3 million in 2025, then declined by 17.33% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $3.5 million in Q2 2026, $4.3 million in Q4 2025, and $154000.0 in Q2 2025.